Sanara MedTech (SMTI) Gross Profit (2010 - 2026)

Sanara MedTech (SMTI) has 16 years of Gross Profit data on file, last reported at $25.9 million in Q1 2026.

• Quarterly Gross Profit rose 19.8% year-over-year to $25.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $99.9 million (up 19.66% YoY) and the FY2025 annual result came in at $95.6 million, up 21.73% from the prior year.
• Gross Profit climbed to $25.9 million in Q1 2026, from $25.7 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $25.9 million in Q1 2026 to a low of $7.0 million in Q1 2022.
• A 5-year average of $17.5 million and a median of $16.6 million in 2024 frame the typical range for Gross Profit.
• Annual changes were most pronounced in 2022 — Gross Profit surged 107.13% — and 2025, when it climbed 6.71%.
• Tracing SMTI's Gross Profit over 5 years: stood at $12.9 million in 2022, then rose by 22.82% to $15.9 million in 2023, then surged by 51.28% to $24.1 million in 2024, then rose by 6.71% to $25.7 million in 2025, then advanced by 0.79% to $25.9 million in 2026.
• The last three Gross Profit figures came in at $25.9 million (Q1 2026), $25.7 million (Q4 2025), and $24.5 million (Q3 2025), per Business Quant data.